semaglutide

The 20 Hottest Pipeline Drugs to Watch in 2019
BioSpace
Sun, 01/6/19 - 02:09 pm
VX-659 + tezacaftor + ivacaftor
semaglutide
JCAR017
ARGX-113
aducanumab
elafibranor
NKTR-214
DS-8201
GSK2857916
ozanimod
SGT-001
valoctocogene roxaparvovec
voxelotor
3 Biotechs With Potential Blockbusters Near the Finish Line
Motley Fool
Tue, 12/18/18 - 12:48 pm
Vertex Pharmaceuticals
VX-659 + tezacaftor + ivacaftor
Celgene
JCAR017
Novo Nordisk
semaglutide
Novo Nordisk’s Semaglutide Hits Mark in Type 2 Diabetes Trial
BioSpace
Mon, 08/20/18 - 10:42 pm
Novo Nordisk
clinical trials
semaglutide
type 2 diabetes
Novo Nordisk trumpets more Januvia-topping data for oral semaglutide
Fierce Pharma
Fri, 06/29/18 - 10:20 am
Novo Nordisk
semaglutide
Merck
Januvia
HbA1C
Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia
Fierce Pharma
Thu, 06/21/18 - 10:58 pm
Novo Nordisk
diabetes
semaglutide
Victoza
Merck
Januvia
Novo Nordisk's oral diabetes drug beats Jardiance in study
Yahoo/Reuters
Tue, 05/29/18 - 11:07 pm
diabetes
Novo Nordisk
semaglutide
Jardiance
Eli Lilly
Novo Nordisk's semaglutide spurs major weight loss in phase 2 obesity study
Fierce Pharma
Mon, 03/19/18 - 11:40 pm
Novo Nordisk
obesity
semaglutide
In a turf war with Eli Lilly, Novo Nordisk steps off with positive PhIII for its challenging oral GLP-1 drug
Endpoints
Thu, 02/22/18 - 09:12 am
Novo Nordisk
Eli Lilly
diabetes
clinical trials
semaglutide
Trulicity
Bring on Novo Nordisk’s semaglutide, Eli Lilly says. We’re ready
Fierce Pharma
Mon, 02/12/18 - 11:00 am
Novo Nordisk
semaglutide
Eli Lilly
Ozempic
Trulicity
5 Biggest New Drugs of 2018
Motley Fool
Sun, 01/7/18 - 12:35 pm
Gilead Sciences
Bictegravir/F/TAF
Novo Nordisk
semaglutide
Ozempic
Incyte
epacadostat
AbbVie
Rova-T
Celgene
ozanimod
These 2 European Pharmas Grabbed Upgrades Ahead Of 2018 News
Investors Business Daily
Tue, 01/2/18 - 11:42 am
Europe
AstraZeneca
Lynparza
ovarian cancer
Novo Nordisk
diabetes
semaglutide
The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate
Endpoints
Sun, 12/17/17 - 11:47 am
drug launches
Bictegravir/F/TAF
Gilead Sciences
semaglutide
Novo Nordisk
epacadostat
Incyte
Rova-T
AbbVie
ozanimod
Celgene
apalutamide
JNJ
Elagolix
AVXS-101
AveXis
lanadelumab
Shire
Epidiolex
GW Pharma
Novo gains FDA OK for semaglutide
BioPharma Dive
Wed, 12/6/17 - 11:48 pm
Novo Nordisk
semaglutide
FDA
Ozempic
type 2 diabetes
Building on impressive data, Novo Nordisk maps big PhIII obesity program for blockbuster hopeful semaglutide
Endpoints
Tue, 11/21/17 - 11:28 am
Novo Nordisk
obesity
semaglutide
With FDA panel backing, Novo Nordisk prepares for semaglutide's potential launch
Fierce Biotech
Thu, 10/19/17 - 12:00 pm
FDA
Novo Nordisk
semaglutide
diabetes
Novo's experimental diabetes drug likely to compete with Trulicity
Medical Marketing and Media
Tue, 10/17/17 - 08:29 pm
Novo Nordisk
diabetes
Trulicity
semaglutide
FDA gives Novo Nordisk top grades for its diabetes drug semaglutide, but retinopathy remains key
Endpoints
Mon, 10/16/17 - 09:42 am
FDA
Novo Nordisk
diabetes
semaglutide
diabetic retinopathy
Diabetes drugs must prove their value to payers, analysts say
Medical Marketing and Media
Tue, 08/22/17 - 06:48 pm
diabetes
payers
Novo Nordisk
semaglutide
Eli Lilly
Trulicity
Novo focuses on new obesity therapy Semaglutide
GoInPharma
Tue, 08/15/17 - 09:31 am
Novo Nordisk
obesity
semaglutide
Can Novo’s blockbuster push on obesity drug semaglutide succeed where others failed?
Endpoints
Thu, 08/10/17 - 11:36 am
Novo Nordisk
semaglutide
obesity

Pages